Budget Amount *help |
¥24,700,000 (Direct Cost: ¥19,000,000、Indirect Cost: ¥5,700,000)
Fiscal Year 2015: ¥7,930,000 (Direct Cost: ¥6,100,000、Indirect Cost: ¥1,830,000)
Fiscal Year 2014: ¥7,930,000 (Direct Cost: ¥6,100,000、Indirect Cost: ¥1,830,000)
Fiscal Year 2013: ¥8,840,000 (Direct Cost: ¥6,800,000、Indirect Cost: ¥2,040,000)
|
Outline of Final Research Achievements |
hiPSCs and hESCs have abilities to proliferate eternally (self-renewal) and differentiate into any cell types such as cardiomyocytes and neurons (pluripotency). Therefore, hiPSCs and hESCs gain a lot of attentions as cell sources for regenerative medicine. I have discovered a hiPSC/hESC-specific lectin called rBC2LCN. In this study, I analyzed the binding mechanisms of rBC2LCN to hiPSCs/hESCs, clarified the functions of glycans recognized by the lectin, and developed technologies to detect and eliminate undifferentiated cells.
|